Biosimilars: The next chapter for biologics begins
Biosimilars - biologic drugs with a high degree of similarity to previously-approved innovator biologics, hit full steam in 2019, with…
transforming clinical trials
-
-
Programmatic approach: An innovative model for drug development that delivers speed and flexibility from candidate to proof-of-concept
It is estimated that 70-80% of biotech firms still follow a study-by-study approach for their drug development program, often driven…
-
Finding commercial success by integrating development, regulatory and market access strategies from the get-go
When bringing a drug to market, there is a range of scientific, clinical, regulatory and market access challenges that pharmaceutical…
-
AI and automation: Transforming product and safety vigilance data into smart, personalized insights
Patients are using powerful drugs and medical devices, which are extremely efficient at enhancing and saving lives, but can come…
-
Getting personal: How precision medicine is shaping the future of healthcare
Many people take for granted that the medication they have been prescribed by their physician will adequately treat or cure…
-
Functional Service Providers: A flexible trial staffing model that’s capable of taking on biomarker data management
As large pharma, biotech, and medical device organizations feel the economic pinch of escalating costs, stricter regulations, and fiercer competition,…
-
Medical device and diagnostic solutions: A life cycle development model that moves your device ahead of the game
The medical device and diagnostic (MDD) industry is experiencing a transformational era due to huge advances in technologies such as…
-
How mobile health, local sample collections and virtual models are redefining where clinical trials happen
We live in an era where there is an expectation of immediate results. We connect with other people and with…
-
Deciphering real world data to accelerate clinical trials
As clinical studies get more complex and pressures to deliver increase, trial sponsors are seeking more efficient ways to execute…
-
How patient centricity is enabling the reality of virtual trials and mHealth
It’s a well-cited fact that the greatest challenge facing clinical trials today is patient recruitment and retention. Low rates of…
